Terpene Synthases and Genetic Variation

Core science

Cannabis contains a diverse terpene-synthase gene family. Functional characterization in 2017 identified mono- and sesquiterpene synthases whose products include beta-myrcene, beta-ocimene, limonene, alpha-pinene, beta-caryophyllene, alpha-humulene, and other compounds found in cannabis resin.

Genome-scale analysis published in 2019 described 55 terpene-synthase genes or gene models with genomic context and tissue-specific expression evidence, expanding the known CsTPS family beyond the smaller set of enzymes that had been biochemically characterized.

Sequence similarity is not the same as demonstrated function. Bioinformatic annotation can identify likely TPS family members; transcript data can show where a gene is expressed; recombinant enzyme assays can establish catalytic capability; and plant metabolite association can connect that capability to an intact biological phenotype. These are different evidence levels.

Cannabis TPS enzymes can be multiproduct, and the same volatile compound can be generated by more than one synthase. Consequently, one chemical peak does not necessarily identify one causal gene, and one gene does not necessarily predict one exclusive aroma compound.

Final volatile phenotype depends on more than TPS sequence. Gene copy and allele variation, regulatory expression, precursor pools, trichome development, tissue position, environment, postharvest loss, oxidation, and analytical method can all change the measured profile.

Why this matters in cultivation

• Use replicated volatile phenotypes, stable plant identity, and validated genetic markers when selecting for terpene profiles; do not assign aroma from sequence similarity alone.
• When a candidate TPS marker is used in breeding, validate its association in the target population and retain chemical confirmation across development and environments.
• Distinguish gene presence, transcript expression, enzyme function, tissue chemistry, and sensory phenotype in records and educational claims.
• Do not infer that two plants are genetically identical because they share one dominant terpene or a similar total-terpene value.

Measure and record

Common misconceptions

Evidence limits and uncertainty

Cannabis TPS gene-family diversity and several enzyme functions are supported by genomic, transcriptomic, and recombinant-enzyme evidence. However, gene annotation, copy number, allelic variation, expression, and final volatile phenotype are not interchangeable. Marker-to-profile relationships remain population- and environment-dependent, and only a subset of predicted genes has direct biochemical characterization.

Check your reasoning

• For "Terpene Synthases and Genetic Variation", explain the mechanism behind this objective: Connect cannabis terpene-synthase gene-family diversity with functional enzyme assays, multiproduct catalysis, tissue expression, inherited volatile profiles, and the limits of predicting aroma from sequence or markers alone. Which observation or measurement would best test whether that mechanism is operating in the real crop?
• A learner claims, "Each cannabis aroma compound has one unique terpene-synthase gene." Use the lesson’s science and evidence limits to explain why that claim is unreliable, then name one observation or measurement that could separate the competing explanations.
• Applied case — Use replicated volatile phenotypes, stable plant identity, and validated genetic markers when selecting for terpene profiles; do not assign aroma from sequence similarity alone. Build a verification plan using the lesson’s record set (Genetic identity, Expression, Functional assay). What would you compare before and after the action, and what result would make you revise the original interpretation?

Related lessons

Sources and evidence

1. Booth JK, Page JE, Bohlmann J. (2017). Terpene synthases from Cannabis sativa. PLOS ONE 12:e0173911. Identified and functionally characterized cannabis mono- and sesquiterpene synthases and demonstrated both single- and multiproduct enzymes.
2. Allen KD et al. (2019). Genomic characterization of the complete terpene synthase gene family from Cannabis sativa. PLOS ONE 14:e0222363. Described 55 TPS genes/gene models with genomic context and tissue-specific expression and documented extensive commercial terpene-profile variation.
3. Controlled Volume 13 manuscript v1.0 requires bioinformatic annotation, functional assays, plant expression, metabolite phenotype, and sensory claims to remain distinct evidence levels.